Celcuity Inc. (NASDAQ:CELC) Given Consensus Rating of “Buy” by Analysts

Shares of Celcuity Inc. (NASDAQ:CELC) have been given an average recommendation of “Buy” by the seven analysts that are presently covering the stock, Marketbeat.com reports. Six research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $30.17.

A number of analysts have recently commented on the stock. Needham & Company LLC reiterated a “buy” rating and issued a $29.00 price target on shares of Celcuity in a research note on Tuesday, April 1st. HC Wainwright reaffirmed a “buy” rating and issued a $27.00 target price on shares of Celcuity in a research report on Tuesday, April 1st.

Institutional Trading of Celcuity

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Wellington Management Group LLP grew its position in shares of Celcuity by 21.6% during the 4th quarter. Wellington Management Group LLP now owns 62,776 shares of the company’s stock valued at $822,000 after acquiring an additional 11,165 shares during the period. Wealth Enhancement Advisory Services LLC lifted its position in Celcuity by 19.7% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 26,377 shares of the company’s stock valued at $345,000 after purchasing an additional 4,341 shares in the last quarter. Soleus Capital Management L.P. grew its holdings in Celcuity by 106.0% during the fourth quarter. Soleus Capital Management L.P. now owns 2,565,087 shares of the company’s stock valued at $33,577,000 after purchasing an additional 1,319,700 shares during the period. Shay Capital LLC purchased a new stake in Celcuity in the fourth quarter worth about $187,000. Finally, Nuveen Asset Management LLC raised its stake in shares of Celcuity by 10.8% in the fourth quarter. Nuveen Asset Management LLC now owns 69,587 shares of the company’s stock worth $911,000 after buying an additional 6,785 shares during the period. 63.33% of the stock is owned by hedge funds and other institutional investors.

Celcuity Trading Down 2.3 %

NASDAQ CELC opened at $8.65 on Friday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 10.36 and a current ratio of 10.35. Celcuity has a fifty-two week low of $7.70 and a fifty-two week high of $20.15. The stock has a market cap of $321.17 million, a P/E ratio of -3.31 and a beta of 0.44. The stock has a 50 day simple moving average of $10.99 and a two-hundred day simple moving average of $12.76.

Celcuity (NASDAQ:CELC) last released its quarterly earnings results on Monday, March 31st. The company reported ($0.85) earnings per share for the quarter, missing the consensus estimate of ($0.72) by ($0.13). On average, analysts forecast that Celcuity will post -2.62 earnings per share for the current year.

Celcuity Company Profile

Celcuity Inc, a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment.